Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.03 |
mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |